Currentprogressinthe pharmacologicaltherapyof fibromyalgia

[1]  S. Malnick,et al.  Patients treated by tegaserod for irritable bowel syndrome with constipation showed significant improvement in fibromyalgia symptoms. A pilot study , 2009, Clinical Rheumatology.

[2]  P. Wood,et al.  An Elephant Among Us: The Role of Dopamine in the Pathophysiology of Fibromyalgia , 2009, The Journal of Rheumatology.

[3]  W. Müller,et al.  The classification of fibromyalgia syndrome , 2007, Rheumatology International.

[4]  M. Seidel,et al.  5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndrome , 2007, Rheumatology International.

[5]  K. Mackie,et al.  Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors , 2007, Nature Neuroscience.

[6]  R. Bennett,et al.  Growth hormone perturbations in fibromyalgia: a review. , 2007, Seminars in arthritis and rheumatism.

[7]  T. Schwartz,et al.  Modafinil treatment for fatigue associated with fibromyalgia. , 2007, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[8]  B. Fiebich,et al.  New treatment options using 5-HT3 receptor antagonists in rheumatic diseases. , 2006, Current topics in medicinal chemistry.

[9]  D. Dinges,et al.  Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss* , 2006, Current medical research and opinion.

[10]  A. Holman,et al.  A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. , 2005, Arthritis and rheumatism.

[11]  David A. Williams,et al.  Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. , 2003, Arthritis and rheumatism.

[12]  W. Pachas.  Modafinil for the treatment of fatigue of fibromyalgia. , 2003, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[13]  C. Nemeroff,et al.  Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing. , 2002, The Journal of clinical psychiatry.

[14]  D. Behar,et al.  Modafinil in fibromyalgia treatment. , 2001, The Journal of Neuropsychiatry and Clinical Neurosciences.

[15]  R. E. Boyd.  Alpha2-adrenergic receptor agonists as analgesics. , 2001, Current topics in medicinal chemistry.

[16]  A. Eschalier,et al.  Effect of tachykinin receptor antagonists in experimental neuropathic pain. , 1998, European journal of pharmacology.

[17]  P. Sarzi-Puttini,et al.  The genetics of fibromyalgia syndrome. , 2007, Pharmacogenomics.

[18]  C. Hornfeldt,et al.  The Xyrem® Risk Management Program , 2004, Drug safety.